90
Views
2
CrossRef citations to date
0
Altmetric
BRIEF REPORT

Bipolar disorder susceptibility region on chromosome 3q29 not confirmed in a case–control association study

, , , , , , , , , , & show all
Pages 309-315 | Received 12 Aug 2010, Accepted 23 Nov 2010, Published online: 17 Feb 2011

References

  • Bailer U, Leisch F, Meszaros K, Lenzinger E, Willinger U, Strobl R, . 2002. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatry 52:40–52.
  • Ballif BC, Theisen A, Coppinger J, Gowans GC, Hersh JH, Madan-Khetarpal S, . 2008. Expanding the clinical phenotype of the 3q29 microdeltion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet 28:1–8.
  • Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265.
  • Bauer MS, Altshuler L, Evans DR, Beresford T, Williford WO, Hauger R. 2005. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord 85(3): 301–315.
  • Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. 2001. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125:279–284.
  • Beck AT, Steer RA. 1984. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40:1365–1367.
  • Clayton-Smith J, Giblin C, Smith RA, Dunn C, Willat L. 2010. Familial 3q29 microdeletion syndrome providing further evidence of involvement of the 3q29 region in bipolar disorder. Clin Dysmorphol 19(3):128–132.
  • Digilio MC, Bernardini L, Mingarelli R, Capolino R, Capalbo A, Giuffrida MG, . 2009. 3q29 Microdeletion: a mental retardation disorder unassociated with a recognizable phenotype in two mother-daughter pairs. Am J Med Genet A 149A(8): 1777–1781.
  • Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115–121.
  • Dupont WD, Plummer WD. 1990. Power and sample-size calculations – a review and computer-program. Control Clin Trials 11(2):116–128.
  • Farmer A, Cosyns P, Leboyer M, Maier W, Mors O, Sargeant M, . 1993. A SCAN-SADS comparison study of psychotic subjects and their first-degree relatives. Eur Arch Psychiatry Clin Neurosci 242(6):352–356.
  • Freeman B, Powell J, Ball D, Hill L, Craig I, Plomin R. 1997. DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations. Behav Genet 27:251–257.
  • Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW. 2003. DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet 33(1):67–72.
  • Gaysina D, Cohen-Woods S, Chow PC, Martucci L, Schosser A, Ball HA, . 2009. Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS). Am J Med Genet B Neuropsychiatr Genet 150B(6):836–844.
  • Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao S. 1997. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 27(5):1079–1089.
  • Koolen DA, Nillesen WM, Versteeg MH, Merkx GF, Knoers NV, Kets M, . 2004. Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA). J Med Genet 41(12):892–899.
  • Krepischi-Santos AC, Vianna-Morgante AM, Jehee FS, Passos-Bueno MR, Knijnenburg J, Szuhai K, . 2006. Whole-genome array-CGH screening in undiagnosed syndromatic patients: old syndromes revisited and new alterations. Cytogenet Genome Res 115(3–4):254–261.
  • McGuffin P, Katz R, Aldrich J. 1986. Past and present state examination: the assessment of ‘lifetime ever’ psychopathology. Psychological Medicine 16:461–465.
  • McGuffin P, Farmer A, Harvey I. 1991. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48(8):764–770.
  • Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, . 2007. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 64(5):543–552.
  • Rossi E, Piccini F, Zollino M, Neri G, Caselli D, Tenconi R, . 2001. Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations. J Med Genet 38(6):417–420.
  • Schosser A, Fuchs K, Leisch F, Bailer U, Meszaros K, Lenzinger E, . 2004. Possible linkage of schizophrenia and bipolar affective disorder to chromosome 3q29: a follow-up. J Psychiatr Res 38(3):357–367.
  • Schosser A, Fuchs K, Scharl T, Leisch F, Bailer U, Kasper S, . 2007. Additional support for linkage of schizophrenia and bipolar disorder to chromosome 3q29. Eur Neuropsychopharmacol 17(6–7):501–505.
  • Shao L, Shaw CA, Lu XY, Sahoo T, Bacino CA, Lalani SR, . 2008. Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: a study of 5,380 cases. Am J Med Genet A 146A(17):2242–2251.
  • Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, . 2004. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 161(12):2222–2229.
  • Spitzer RL, Endicott J. 1987. Schedule for affective disorder and schizophrenia (SADS). New York: Biometrics Research Division, New York State Psychiatric Institute.
  • Willatt L, Cox J, Barber J, Cabanas ED, Collins A, Donnai D, . 2005. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet 77(1):154–160.
  • Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, . 1990. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 47:589–593.
  • Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. 1997. Strukturiertes Klinisches Interview für DSM-IV, Achse I (SKID).Hogrefe: Göttingen (German Version of SCID-I).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.